Gabe S Sonke

Breast Cancer Res Treat 2019 Dec 30;178(3):665-681. Epub 2019 Aug 30.

Department of Research, Netherlands Comprehensive Cancer Organisation, P.O. Box 19079, 3501 DB, Utrecht, The Netherlands.

N Engl J Med 2019 Dec 11. Epub 2019 Dec 11.

From the David Geffen School of Medicine at UCLA, Los Angeles (D.J.S.); Multidisciplinary Breast Center, Universitair Ziekenhuis Leuven, Leuven (P.N.), and Centre Hospitalier Universitaire Liège and Liege University, Liege (G.J.) - all in Belgium; the British Columbia Cancer Agency, Vancouver, Canada (S.C.); University Hospital Erlangen, Comprehensive Cancer Center Erlangen-European Metropolitan Region of Nuremberg, and Department of Gynecology and Obstetrics, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and the Practice for Hematology and Internal Oncology, Velbert (A.N.) - all in Germany; Istituto Nazionale Tumori Fondazione G. Pascale, Naples (M.D.L.), and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (G.V.B.) - both in Italy; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); New York University Langone Health, New York (F.J.E.); Instituto de Investigación Sanitaria Gregorio Marañon, Centro de Investigación Biomédica en Red de Cáncer, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.), and Hospital Universitario Virgen Macarena, Department of Medicine, Universidad de Sevilla, Seville (L.D.C.-M.) - both in Spain; Netherlands Cancer Institute-Borstkanker Onderzoek Groep Study Center, Amsterdam (G.S.S.); Highlands Oncology Group, Fayetteville, AR (J.T.B.); Institut Régional du Cancer, Strasbourg, France (X.P.); Novartis Pharmaceuticals, East Hanover, NJ (M.S., A.C., K.R.-L.); and Novartis Pharma, Basel, Switzerland (Y.W., T.T.).

Eur J Heart Fail 2019 Nov 6. Epub 2019 Nov 6.

Department of Epidemiology & Biostatistics, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Eur J Heart Fail 2019 Nov 12. Epub 2019 Nov 12.

Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Med Sci Sports Exerc 2019 Sep 12. Epub 2019 Sep 12.

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Biostatistics, Amsterdam Public Health research institute,, Amsterdam, The Netherlands.

Clin Cancer Res 2019 Aug 10;25(16):4985-4992. Epub 2019 May 10.

Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

J Clin Oncol 2019 Aug 28;37(23):2041-2050. Epub 2019 Jun 28.

1The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Support Care Cancer 2019 Aug 8. Epub 2019 Aug 8.

Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Nat Med 2019 Jul;25(7):1175

Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Nat Med 2019 06 13;25(6):920-928. Epub 2019 May 13.

Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Ned Tijdschr Geneeskd 2019 May 31;163. Epub 2019 May 31.

UMC Utrecht, divisie Beeld en Kanker, Utrecht.

BMJ Open 2019 03 30;9(3):e024450. Epub 2019 Mar 30.

Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Int J Cancer 2019 01 28;144(2):263-272. Epub 2018 Nov 28.

Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.

J Natl Cancer Inst 2019 Jan 30. Epub 2019 Jan 30.

Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.

N Engl J Med 2018 12 21;379(26):2495-2505. Epub 2018 Oct 21.

From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan-Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica, Rome (G.S.) - both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona (A. Oaknin), and M.D. Anderson Cancer Centre Madrid, Madrid (A.G.-M.) - both in Spain; University of New South Wales Clinical School, Prince of Wales Hospital, Randwick, Australia (M.F.); St. Petersburg City Oncology Dispensary, St. Petersburg, Russia (A. Lisyanskaya); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, Paris (A.F., A. Leary), Institut Bergonié, Comprehensive Cancer Center, Bordeaux (A.F.), and Gustave-Roussy Cancer Campus, Villejuif (A. Leary) - all in France; the Netherlands Cancer Institute, Amsterdam (G.S.S.); Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (C.G.), the Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London (S.B.), and AstraZeneca, Cambridge (R.B.) - all in the United Kingdom; Princess Margaret Cancer Centre, Toronto (A. Oza); Memorial Sloan Kettering Cancer Center, New York (C.A.); Froedtert and the Medical College of Wisconsin, Milwaukee (W.B.); Women and Infants Hospital, Providence, RI (C.M., P.D.); Dana-Farber Cancer Institute, Boston (J.L.); and AstraZeneca, Gaithersburg, MD (E.S.L.).

Lancet Oncol 2018 12 6;19(12):1630-1640. Epub 2018 Nov 6.

Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address:

Ned Tijdschr Geneeskd 2018 12 5;162. Epub 2018 Dec 5.

Gold Coast University Hospital, dep. Emergency Medicine, Southport, Australië.

J Natl Cancer Inst 2018 11;110(11):1190-1200

Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, AB, Canada.

J Clin Oncol 2018 08 3;36(24):2465-2472. Epub 2018 Jun 3.

Dennis J. Slamon, University of California Los Angeles Medical Center, Santa Monica, CA; Patrick Neven, Multidisciplinary Breast Centre, Universitair Ziekenhuis, Leuven; Guy Jerusalem, Centre Hospitalier Universitaire de Liege and Liege University, Liège, Belgium; Stephen Chia, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Peter A. Fasching, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen; Arnd Nusch, Practice for Hematology and Internal Oncology, Velbert, Germany; Michelino De Laurentiis, Istituto Nazionale Tumori "Fondazione G. Pascale," Naples; Giulia Val Bianchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy; Seock-Ah Im, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; Katarina Petrakova, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Francisco J. Esteva, New York University Langone Health, New York, NY; Miguel Martín, Instituto de Investigacion Sanitaria Gregorio Marañon, Centro de Investigación Biomédica en Red de Cáncer, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid; Luis De la Cruz-Merino, Hospital Universitario Virgen Macarena, Seville, Spain; Gabe S. Sonke, Netherlands Cancer Institute/Borstkanker Onderzoek Groep Study Center, Amsterdam, the Netherlands; J. Thaddeus Beck, Highlands Oncology Group, Fayetteville, AR; Xavier Pivot, Institut Régional du Cancer, Strasbourg, France; Gena Vidam, Karen Rodriguez Lorenc, Michelle Miller, and Tetiana Taran, Novartis Pharmaceuticals, East Hanover, NJ; and Yingbo Wang, Novartis Pharma, Basel, Switzerland.

Br J Cancer 2018 08 1;119(4):408-418. Epub 2018 Aug 1.

Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Eur J Health Econ 2018 Jul 30;19(6):893-904. Epub 2017 Oct 30.

Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

N Engl J Med 2018 04;378(14):1363-1364

Netherlands Cancer Institute, Amsterdam, the Netherlands

Breast Cancer Res Treat 2018 02 22;167(3):659-669. Epub 2017 Oct 22.

Sarah Cannon Research Institute, 250 25th Avenue North #100, Nashville, TN, 37203, USA.

Breast Cancer Res Treat 2018 Feb 21;168(1):127-134. Epub 2017 Nov 21.

University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

ESMO Open 2018 2;3(2):e000285. Epub 2018 Feb 2.

Cancer Control, Management of Noncommunicable Diseases Unit Department for Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention (NVI), World Health Organization, Geneva, Switzerland.

Int J Colorectal Dis 2018 Jan 9;33(1):29-40. Epub 2017 Nov 9.

Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Gynecol Oncol 2018 01 10;148(1):56-61. Epub 2017 Nov 10.

Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.

N Engl J Med 2018 01;378(3):230-240

From the Departments of Gynecology (W.J.D., S.N.K.), Biometrics (K.S., H.T.), Surgical Oncology (A.G.J.A.), Pathology (K.K.V.V.), and Medical Oncology (S.N.K., G.S.S.) and the Division of Psychosocial Research and Epidemiology (J.M.K., N.K.A.), the Netherlands Cancer Institute, Amsterdam, the Center for Gynecologic Oncology Amsterdam, Amsterdam (W.J.D., S.N.K., J.V.), the Dutch Gynecologic Oncology Group (W.J.D., J.H.S.L., H.W.R.S., R.H.M.H., J.V., H.J.A., L.F.A.G.M., G.S.S.), the Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam (J.V.), the Department of Obstetrics and Gynecology, Sint Antonius Hospital, Nieuwegein (J.H.S.L.), the Department of Gynecologic Oncology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht (H.W.R.S.), the Departments of Gynecology and Obstetrics (R.H.M.H.) and Surgery (I.H.J.T.H.), Catharina Hospital, Eindhoven, the Dutch Peritoneal Oncology Group (I.H.J.T.H., A.G.J.A.), the Department of Gynecologic Oncology, University of Groningen, University Medical Center Groningen, Groningen (H.J.A.), and the Department of Gynecologic Oncology, Radboud University Medical Center, Nijmegen (L.F.A.G.M.) - all in the Netherlands; and the Department of Surgery, Aarhus University Hospital, Aarhus, Denmark (V.J.V.).

JAMA Oncol 2017 12;3(12):1634-1639

Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

JAMA Oncol 2017 12;3(12):1733-1734

Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands

PLoS One 2017 22;12(5):e0176782. Epub 2017 May 22.

Department of Radiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.

Drugs 2017 Aug;77(12):1313-1336

Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.

Breast Cancer Res Treat 2017 Jul 21;164(1):99-106. Epub 2017 Apr 21.

Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Tumour Biol 2017 06;39(6):1010428317701629

6 Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands.

Cancer Imaging 2017 May 25;17(1):15. Epub 2017 May 25.

Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Crit Rev Oncol Hematol 2017 Apr 17;112:198-207. Epub 2017 Feb 17.

Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Health Technology and Services Research, MB-HTSR, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands. Electronic address:

Palliat Med 2017 03 19;31(3):239-246. Epub 2016 Aug 19.

1 Department of Registry and Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.

Clin Cancer Res 2017 Mar 12;23(5):1236-1241. Epub 2016 Sep 12.

Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Eur J Cancer 2017 03 10;74:47-54. Epub 2017 Feb 10.

Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address:

Cancer Treat Rev 2017 Jan 5;52:91-104. Epub 2016 Dec 5.

Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Amsterdam School of Communication Research (ASCoR), University of Amsterdam, Amsterdam, The Netherlands. Electronic address:

J Clin Oncol 2016 12 28;34(36):4354-4361. Epub 2016 Oct 28.

Suzanne Leijen, Robin M.J.M. van Geel, Gabe S. Sonke, Daphne de Jong, Efraim H. Rosenberg, Serena Marchetti, Dick Pluim, Erik van Werkhoven, Jos H. Beijnen, and Jan H.M. Schellens, The Netherlands Cancer Institute, Amsterdam; Jos H. Beijnen and Jan H.M. Schellens, Utrecht University, Utrecht, the Netherlands; and Shelonitda Rose, Mark A. Lee, and Tomoko Freshwater, Merck, Kenilworth, NJ.

N Engl J Med 2016 11 7;375(18):1738-1748. Epub 2016 Oct 7.

From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.).

Breast 2016 Oct 5;29:153-9. Epub 2016 Aug 5.

Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address:

Breast Cancer Res Treat 2016 09;159(2):393

Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.

Psychooncology 2016 08 17;25(8):964-70. Epub 2015 Aug 17.

Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Breast Cancer Res Treat 2016 07 29;158(2):361-71. Epub 2016 Jun 29.

Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.

J Clin Oncol 2016 06 14;34(18):2107-14. Epub 2016 Mar 14.

Kim C. Aalders, Emily L. Postma, and Thijs van Dalen, Diakonessenhuis; Margriet van der Heiden-van der Loo and Sabine Siesling, Netherlands Comprehensive Cancer Organization; Paul J. van Diest, University Medical Center Utrecht, Utrecht; Luc J. Strobbe, Canisius Wilhelmina Hospital, Nijmegen; Gabe S. Sonke, Netherlands Cancer Institute, Amsterdam; Liesbeth J. Boersma, University Hospital Maastricht, Maastricht; and Sabine Siesling, University of Twente, Enschede, the Netherlands.

Trials 2016 06 21;17(1):293. Epub 2016 Jun 21.

Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.

PLoS One 2015 10;10(4):e0120832. Epub 2015 Apr 10.

Department of Health Technology and Services Research, MIRA Institute of Biomedical Technology and Technical Medicine, Twente University, Enschede, The Netherlands; Department of Registration and Research, Comprehensive Cancer Centre the Netherlands (IKNL), Utrecht, the Netherlands.

Lancet Oncol 2015 Dec 23;16(16):1639-50. Epub 2015 Oct 23.

Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands. Electronic address:

Cureus 2015 Dec 24;7(12):e433. Epub 2015 Dec 24.

Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.

BMJ Open 2015 Nov 25;5(11):e009009. Epub 2015 Nov 25.

Department of Registry & Research, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.

Breast Cancer Res Treat 2015 Aug 11;152(3):627-36. Epub 2015 Jul 11.

Department of Health Technology and Services Research (HTSR), MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands,

Br J Cancer 2015 Jul 16;113(3):396-402. Epub 2015 Jul 16.

1] Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands [2] Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, Utrecht 3584 CG, The Netherlands.

J Clin Oncol 2015 Jun 27;33(17):1918-27. Epub 2015 Apr 27.

Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Jacobien M. Kieffer, Marianne de Maaker-Berkhof, Gabe S. Sonke, Neil K. Aaronson, The Netherlands Cancer Institute; Edwin Geleijn, Laurien M. Buffart, and Epie Boven, VU University Medical Center; Laurien M. Buffart, EMGO Institute for Health and Care Research; Maud M. Geenen, Sint Lucas Andreas Hospital; Jetske M. Meerum Terwogt, Onze Lieve Vrouwe Gasthuis; Jeanette A.J.H. Hellendoom-van Vreeswijk, Comprehensive Cancer Centre of the Netherlands, Amsterdam; Jolanda Schrama, Spaarne Hospital, Hoofddorp; Aart van Bochove and Simone M. van den Heiligenberg, Esperanz, North Holland; Aart van Bochove, Zaans Medisch Centrum, Zaandam; Vera Lustig, Flevohospital, Almere; Simone M. van den Heiligenberg, Westfries Gasthuis, Hoorn; and Carolien H. Smorenburg, Medical Center Alkmaar, Alkmaar, the Netherlands.

Obstet Gynecol Int 2015 27;2015:464123. Epub 2015 May 27.

Centre for Gynaecologic Oncology Amsterdam, Academic Medical Centre, Amsterdam, Netherlands.

N Engl J Med 2015 05;372(20):1964

Ann Surg 2015 Feb;261(2):378-82

Departments of *Surgical Oncology †Pathology ‡Radiology §Medical Oncology; and ¶Statistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Lancet Oncol 2015 Jan 4;16(1):87-97. Epub 2014 Dec 4.

Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia.

PLoS One 2013 6;8(11):e77959. Epub 2013 Nov 6.

Comprehensive Cancer Center The Netherlands, Department of Registry and Research, Utrecht, The Netherlands ; University of Amsterdam, Department of Philosophy, Amsterdam, The Netherlands.

Int J Gynecol Cancer 2014 Mar;24(3):496-505

*Department of Gynecology, Center for Gynecologic Oncology Amsterdam, and †Department of Medical Oncology, Academic Medical Center; and ‡Department of Medical Oncology, Netherlands Cancer Institute, and Department of Research, Comprehensive Cancer Centre Netherlands (IKNL), Amsterdam, the Netherlands.

BMJ 2014 Mar 25;348:g2312. Epub 2014 Mar 25.

Comprehensive Cancer Centre the Netherlands (IKNL), Rochussentraat 125, 3015 EJ Rotterdam, Netherlands.

Breast J 2013 Jul-Aug;19(4):419-26. Epub 2013 May 20.

Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Ann Surg Oncol 2013 Aug 6;20(8):2569-75. Epub 2013 Mar 6.

Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Breast Cancer Res Treat 2013 Jan 1;137(1):213-23. Epub 2012 Dec 1.

Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Breast Cancer Res Treat 2012 Nov 8;136(1):35-43. Epub 2012 Sep 8.

Department of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

BMC Cancer 2010 Dec 7;10:673. Epub 2010 Dec 7.

The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands.

N Engl J Med 2009 Nov;361(20):1995; author reply 1995-6

Cancer Treat Rev 2009 May 9;35(3):228-36. Epub 2008 Dec 9.

Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands.

J Clin Epidemiol 2009 Jan 10;62(1):58-61. Epub 2008 Jul 10.

Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

Clin Infect Dis 2008 Jul;47(1):105-8

Departments of 1Medical Oncology and 2Pathology, Antoni van Leeuwenhoek Hospital-Netherlands Cancer Institute, 1006 BE Amsterdam, The Netherlands.

N Engl J Med 2008 Mar;358(11):1196; author reply 1196-7

Oncol Res 2007 ;16(8):383-7

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.

Am J Cardiol 2007 May 16;99(10):1481. Epub 2007 Mar 16.

Ann Intern Med 2007 May;146(10):757; author reply 757-8

J Urol 2002 Apr;167(4):1734-9

Department of Urology, University Medical Centre St. Radboud, Nijmegen, The Netherlands.

Urology 2002 Mar;59(3):368-72

Department of Urology, University Medical Center, Nijmegen, The, Nijmegen, Netherlands.